Features and development trends in international standardization of Chinese materia medica in ISO/TC 249.
Chinese materia medica
ISO/TC 249
International standardization
Traditional Chinese Medicine
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
26
01
2021
revised:
19
02
2021
accepted:
20
02
2021
pubmed:
27
2
2021
medline:
20
1
2022
entrez:
26
2
2021
Statut:
ppublish
Résumé
Chinese materia medica (CMM) is indispensable component of Traditional Chinese Medicine (TCM) therapy. With the widespread of TCM around the world, the quality control and safe use of CMM become a major concern. This paper introduces the role of ISO standards for industrial development and current development status of CMM standards in ISO/TC 249. Through the comparison of similarities and differences between CMM standards in ISO/TC 249 and pharmacopoeias of main stakeholders, this paper suggests strengthening standard formulation in the following areas to provide more appropriate documents to facilitate the international trade and promote the industrial development of CMM: (1) Develop standards to fill the blanks among the whole industry chain of CMM; (2) Develop standards for new forms of CMM and services; (3) Develop specification and grade standards for CMM with large quantity and high value.
Identifiants
pubmed: 33636352
pii: S1043-6618(21)00103-1
doi: 10.1016/j.phrs.2021.105519
pii:
doi:
Substances chimiques
Drugs, Chinese Herbal
0
Materia Medica
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105519Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.